Background Airway inflammation is considered to be important in asthma but is relatively inaccessible to study. Less Airway inflammation is a major factor in the pathogenesis of asthma. Mast cell and eosinophil infiltration, epithelial damage, and mucus production are characteristic features.' Direct examination of the inflammatory response should help to improve understanding of the pathogenesis and treatment of asthma.
lower respiratory tract were obtained in 76% of first attempts. The mean fall in the forced expiratory volume in one second (FEV1) during inhalation of saline was 5-3% and the maximum fall 20%. Eosinophil and metachromatic cell counts were reproducible (reliability coefficient 0X8 and 0 7 respectively). When compared with sputum from normal subjects sputum from asthmatic patients contained a significantly higher proportion of eosinophils (mean 18-5% (SE 3-8%) v 1-9% (0-6%)) and metachromatic cells (0 50% (0-18%) v 0 039% (0-014%)). In the asthmatic group the differential eosinophil count correlated with the baseline FEVI.
Conclusion Induced sputum is capable of detecting differences in cell counts between normal and asthmatic subjects and merits further development as a potential means of assessing airway inflammation in asthma.
Airway inflammation is a major factor in the pathogenesis of asthma. Mast cell and eosinophil infiltration, epithelial damage, and mucus production are characteristic features.' Direct examination of the inflammatory response should help to improve understanding of the pathogenesis and treatment of asthma.
In patients with stable asthma bronchial biopsy and bronchoalveolar lavage have been used to study airway inflammation2' but discomfort, inconvenience, and risks limit their use. Examination of sputum is a less invasive alternative,5 but sputum cannot always be produced spontaneously. When sputum is not otherwise available induced samples may allow secretions from the lower airways to be sampled.
Sputum induction by inhalation of hypertonic saline has been successfully used to diagnose Pneumocystis carinii pulmonary infections in patients infected with HIV.'
We adapted this method for use in asthmatic subjects and examined (a) the success rate and safety of the method, (b) the reproducibility of cell counts, and (c) the differences in cell counts between normal and asthmatic subjects.
Methods

SUBJECTS
Seventeen normal subjects and 17 subjects with asthma were selected from among the staff (adults) and asthmatic patients and their siblings (adults or children) at the clinics of the Firestone Regional Chest and Allergy Unit and the Health Sciences Centre. All were nonsmokers or ex-smokers of more than five years. None had spontaneous sputum or symptoms of a respiratory tract infection, or had been exposed to a seasonal allergen within the last month. The normal subjects had no past or current symptoms of asthma, a forced expiratory volume in one second (FEVI) >80% of predicted values,9 a ratio of FEV, to vital capacity >70%, and normal airway responsiveness to methacholine (provocative concentration of methacholine causing a 20% fall in FEV, (PC20) >8 mg/ml)'0 (table 1) . The asthmatic subjects had a history of episodic dyspnoea with wheeze in the previous six months and a PC20 methacholine <8 mg/ml ( The volume of sputum was recorded and the sample transferred to a Petri dish, where its macroscopic characteristics were recorded. The quality of the sample was assessed by estimating the volume of lower respiratory tract secretions and the degree of salivary contamination. The volume was assessed by the size and number of plugs; a cumulative size of4-5 x 9 mm was estimated to be necessary to perform all investigations, including total and differential counts. The quality of the sputum sample was scored by (a) visual inspection and inverted microscope examination (no plugs = 0, 4-5 x 9mm= 1,>4-5 x 9mm=2);(b) salivary contamination in total cell counts defined as the percentage of squamous cells among nucleated cells (> 10% = 0, < 10% = 1, 0% = 2); (c) salivary contamination in differential cell counts by assessing the proportion of squamous cells in the slides (too many squamous cells to permit a count = 0, enough squamous cells to permit a count = 1, no squamous cells = 2). A sample score of > 4 was considered to be adequate, of 3 to be intermediate, and of < 2 to be inadequate.
Sputum analysis was performed as described the normal subjects and 5-3% in the asthmatic subjects. The nebulisation had to be stopped only once because the fall in FEV, exceeded 20% (30%); the fall was quickly reversed with an inhaled fl2 agonist.
Ofthe first 34 attempts at sputum inductions, 26 produced adequate samples, one an intermediate sample, and seven inadequate samples. A history of spontaneous sputum production (X2 = 7-65, p < 0-05) but not age, sex, or the presence of asthma (x2 = 0-42, 1-5, 0-24 respectively; df 2; NS) was associated with a better quality of sample.
Of the 12 adults with repeated studies, eight had adequate samples on the first two occasions, two had intermediate samples on the first occasion but adequate samples on subsequent attempts, and one asthmatic subject had only one adequate sample out of two. One normal subject had no adequate sample despite three attempts.
REPRODUCIBILITY OF SPUTUM CELL COUNTS
There was reasonably good reproducibility of 
COMPARISON OF CELL COUNTS BETWEEN --ASTHMATIC AND NORMAL SUBJECTS
There was no difference between asthmatic and normal subjects in total or absolute cell counts. The analyses have therefore been expressed only as differential counts. The differential counts of eosinophils and metachromatic cells from asthmatic subjects were significantly higher than those from normal subjects (fig 2;  table 2 ) and the differential macrophage count ' 6 was lower (p = 0-007, 0-02, and 0-002 respec-0 30 0 36 tively). There was a trend for more neutrophils ay 1 in the sputum from asthmatic subjects, but the difference was not significant (p = 0-051). [2] [3] [4] [5] [6] [7] There were no significant differences in total cell counts, differential counts of intact bronchial group The method showed an increased proportion of eosinophils and metachromatic cells in sputum from asthmatic subjects compared with normal subjects. This result is similar to those previously obtained with spontaneous sputum samples,5 bronchoalveolar lavage fluid,23"82' and bronchial biopsy specimens.4
The mean percentages ofeosinophils and metachromatic cells were higher in induced sputum than in bronchoalveolar lavage samples in patients with mild stable asthma, in whom eosinophils account for < 5% and metachromatic cells <0 5% of the cells.31920 They were lower than sputum counts during an exacerbation of asthma. Lack ofreproducibility ofsputum cell counts has been recognised for some time. 27 The distribution of cells within the specimen may s been not be homogeneous or the recognition of les to different cell types may not be accurate, or both.
sthma. The method of sputum examination in our iffered study was similar to that used in a previous bjects. study on spontaneous sputum, in which the mique reproducibility of total and differential cell iatives counts was good.5 Microscopic selection of the isk.
plugs for analysis is considered to be essential of an to ensure that only lower respiratory tract tum is secretions rather than saliva are selected for the ito the analysis.5 27 Reproducibility in our study, ise the especially of total cell counts, was not as good expec-possibly because induced sputum is less -ample homogeneous than spontaneously produced ract in sputum. Further investigation of the methods ;econd and factors determining reproducibility are required. airway
Our study was not designed to examine *17 and relations between induced sputum cell counts iled f2 and clinical and physiological characteristics of ;ed the asthma. Nevertheless, eosinophil counts dually correlated with the degree of airflow obstrucimatic tion, as has been observed in bronchoalveolar vital lavage samples.2 Our observations suggest that 20%, induced sputum may have a role in the study of ahaled asthma and, perhaps, other lung diseases.
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